CardiAI, an Alberta-based biotechnology company specializing in cutting-edge diagnostic solutions, announced a partnership with Carleton University's Faculty of Engineering and Design, marking a significant milestone in advancing medical diagnostics through the implementation of Electrolyte Gated-FET (EG-FET) biosensor technology.

The partnership aims to harness the potential of EG-FET biosensors for the detection of critical biomarkers in saliva and whole blood, which will not only revolutionize point-of-care diagnostics, but also opens several possibilities to apply the technology to a wider range of health conditions.